Do new drugs increase life expectancy? A critique of a manhattan institute paper

Journal of General Internal Medicine

Volumn 24, Issue 5, 2009, Pages 678-682

  Baker, Dean ^b   Fugh Berman, Adriane ^a,c  

^a GEORGETOWN UNIVERSITY   (United States)

^b Center for Economic and Policy Research   (United States)

^c NONE

Author keywords

Health care costs; Life expectancy; Longevity; Medical innovation; New drugs; Prescription drugs

Indexed keywords

HYDROCODONE; OPIATE; PARACETAMOL; NEW DRUG;

CHRONIC PAIN; COST EFFECTIVENESS ANALYSIS; DRUG FORMULATION; DRUG USE; HEALTH CARE COST; HEALTH CARE QUALITY; HEALTH CARE SYSTEM; HEALTH PROGRAM; HUMAN; INFANT MORTALITY; LIFE EXPECTANCY; MEDICAID; MEDICAL LITERATURE; MEDICARE; NEOPLASM; REVIEW; HEALTH STATUS; NEWBORN; TRENDS;

DRUGS, INVESTIGATIONAL; HEALTH STATUS; HUMANS; INFANT MORTALITY; INFANT, NEWBORN; LIFE EXPECTANCY;

EID: 67349118900     PISSN: 08848734     EISSN: 15251497     Source Type: Journal    
DOI: 10.1007/s11606-009-0954-4     Document Type: Review

References (36)

1. Prescription Drug Trends. Kaiser Family Foundation 2007 (May) Available at http://www.kff.org/rxdrugs/upload/3057-06.pdf. Accessed December 23, 2008.
2. The Value of Medicines: Facts and Figures 2006. Pharmaceutical Research and Manufacturers Association http://www.phrma.org/files/ Value%20of%20Medicine%202006.pdf. Accessed December 24, 2008.
3. EconPapers http://econpapers.repec.org/RAS/pli76.htm. Accessed February 1, 2009.
4. Y Zhang SB Soumerai 2007 Do newer prescription drugs pay for themselves? A reassessment of the evidence Health Affairs 26 880 886
5. B Mintzes J Lexchin 2005 Do higher drug costs lead to better health? Can J Clin Pharmacol 12 1 e22 e27 (Pubitemid 43097179)
6. GE Miller JF Moeller RS Stafford 2005-2006 New cardiovascular drugs: patterns of use and association with non-drug health expenditures Inquiry 42 4 397 412
7. J Lexchin 2003 The siren call of new drugs Expert Rev Pharmacoeconomics Outcomes Res 3 5 513 515 (Pubitemid 37304553)
8. Congressional Budget Office. Issues in Designing a Prescription Drug Benefit for Medicare. Available via the Internet at http://cbo.gov/doc.cfm?index = 3960 or http://cbo.gov/ftpdocs/39xx/doc3960/10-30-PrescriptionDrug.pdf. Accessed December 7, 2008.
9. Lichtenberg F. "Why Has Longevity Increased More in Some States than in Others? The Role of Medical Innovation and Other Factors." New York: Manhattan Institute. 2007; Available via the Internet: http://www.manhattan- institute.org/html/mpr-04.htm. Accessed December 24, 2008.
10. National Center for Health Statistics, CDC. U.S. Decennial Life tables for 1989-1991: Trends and Comparisons;1(3).
11. National Center for Health Statistics, CDC. Deaths, age-adjusted death rates, and life expectancy at birth, by race and sex; and infant mortality rates, by race: United States, final 2003 and preliminary 2004. Available at http://www.cdc.gov/nchs/datawh/statab/unpubd/mortabs.htm. Accessed December 24, 2008.
12. Centers for Disease Control and Prevention 2005 Racial/Ethnic disparities in infant mortality - United States, 1995-2002 MMWR 54 22 553 556
13. CC Lin E Rogot NJ Johnson PD Sorlie E Arias 2003 A further study of life expectancy by socioeconomic factors in the National Longitudinal Mortality Study Ethn Dis 13 2 240 247 (Pubitemid 36701627)
14. S Harper J Lynch S Burris G Davey Smith 2007 Trends in the black-white life expectancy gap in the United States, 1983-2003 JAMA 297 11 1224 1232 (Pubitemid 46465730)
15. ER Meara S Richards 2008 Cutler DM.The gap gets bigger: changes in mortality and life expectancy, by education, 1981-2000 Health Aff (Millwood) 27 2 350 360
16. U.S. Food and Drug Administration. "CDER NDAs Approved in Calendar Years 1990-2004 by Therapeutic Potential and Chemical Type," Washington, D.C.: Food and Drug Administration, 2007 [Available via the Internet: http://www.fda.gov/CDER/rdmt/pstable.htm. Accessed December 24, 2008].
17. IMS Health. Top 10 Products by U.S. Dispensed Prescriptions. Available via the Internet: http://www.imshealth.com/deployedfiles/imshealth/Global/ Content/Document/Top-Line%20Industry%20Data/2006%20Top%2010%20Products%20by%20U. S.%20Dispensed%20Prescriptions.pdf. Accessed December 24, 2008.
18. J Feinglass S Lin J Thompson J Sudano D Dunlop J Song DW Baker 2007 Baseline health, socioeconomic status, and 10-year mortality among older middle-aged Americans: findings from the Health and Retirement Study, 1992-2002 J Gerontol B Psychol Sci Soc Sci 62 4 S209 S217 (Pubitemid 350143567)
19. CC Lin E Rogot NJ Johnson PD Sorlie EA Arias 2003 Further study of life expectancy by socioeconomic factors in the National Longitudinal Mortality Study Ethn Dis 13 2 240 247 (Pubitemid 36701627)
20. P Muennig P Franks H Jia E Lubetkin MR Gold 2005 The income-associated burden of disease in the United States Soc Sci Med 61 9 2018 2026 (Pubitemid 41114870)
21. GK Singh M Siahpush 2006 Widening socioeconomic inequalities in US life expectancy, 1980-2000 Int J Epidemiol 35 4 969 979 (Pubitemid 44540749)
22. CJ Ruhm 2000 Are recessions good for your health? Quarterly Journal of Economics 115 2 617 650
23. CJ Ruhm 2003 Good times make you sick Journal of Health Economics 22 4 637 658 (Pubitemid 36802175)
24. U.S. Department of Commerce, Bureau of Economic Analysis, National Income and Product Accounts, Table 1.1.3, Line 1. Available via the Internet: http://www.bea.gov/national/nipaweb/SelectTable.asp?Selected = N. Accessed December 24, 2008.
25. U.S. Council of Economic Advisors. Economic Report of the President, 2007, Washington, D.C: U.S. Government Printing Office; 2007, Table B-36.
26. Griliches Z. R&D, Education, and Productivity: A Retrospective. Cambridge, MA: Harvard University Press; 2000.
27. WG Manning JP Newhouse N Duan EB Keeler A Leibowitz 1987 Health insurance and the demand for medical care: evidence from a randomized experiment American Economic Review 77 3 251 277
28. Cutler DM, Zeckhauser RJ. The anatomy of health insurance. NBER Working Paper No. W7176. National Bureau of Economic Research; 1999.
29. F Feldman B Dowd 1991 A new estimate of the welfare loss of excess health insurance American Economic Review 81 1 297 301
30. FR Lichtenberg 2001 Are the benefits of newer drugs worth their cost? Evidence from the 1996 MEPS.Health Aff (Millwood) 20 5 241 251
31. Lichtenberg FR. Benefits and Costs of newer drugs: an update. NBER Working Paper no 8996. Cambridge, MA: National Bureau of Economic Research; 2002.
32. Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial Collaborative Research Group 2003 Diuretic versus alpha-blocker as first-step antihypertensive therapy: final results from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) Hypertension 42 3 239 246 (Pubitemid 37093467)
33. RS Keefe RM Bilder SM Davis PD Harvey BW Palmer JM Gold HY Meltzer MF Green G Capuano TS Stroup JP [tmp] McEvoy MS Swartz RA Rosenheck DO Perkins CE Davis JK Hsiao JA Lieberman 2007 CATIE Investigators; Neurocognitive Working Group. Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial Arch Gen Psychiatry 64 6 633 647
34. MS Swartz DO Perkins TS Stroup SM Davis G Capuano RA Rosenheck F Reimherr MF [tmp] McGee RS Keefe JP [tmp] McEvoy JK Hsiao JA Lieberman 2007 CATIE Investigators. Effects of antipsychotic medications on psychosocialfunctioning in patients with chronic schizophrenia: findings from the NIMH CATIE study Am J Psychiatry 164 3 428 436
35. MK Olson 2004 Are novel drugs more risky for patients than less novel drugs? J Health Econ 23 6 1135 1158 (Pubitemid 39535588)
36. KE Lasser PD Allen SJ Woolhandler DU Himmelstein SM Wolfe DH Bor 2002 Timing of new black box warnings and withdrawals for prescription medications JAMA 287 17 2215 2220 (Pubitemid 34441937)